Olatinwo Toyin, Hewitt Ross G, Venuto Rocco C
Division of General Medicine, School of Medicine, State University of New York, Buffalo, NY 14215, USA.
Arch Intern Med. 2004 Feb 9;164(3):333-6. doi: 10.1001/archinte.164.3.333.
The advent of highly active antiretroviral therapy represents a significant advance in medical care for human immunodeficiency virus (HIV)-infected persons. However, not everyone has derived the expected benefits of antiretroviral therapy and HIV-associated diseases such as nephropathy still occur in at-risk populations. Currently, there are no recommendations for screening HIV-positive patients for HIV-associated nephropathy. We propose semiannual screening for proteinuria in HIV-positive African Americans and patients with a family history of renal disease, and provide an algorithm for evaluation.
高效抗逆转录病毒疗法的出现代表了对人类免疫缺陷病毒(HIV)感染者医疗护理的重大进展。然而,并非所有人都从抗逆转录病毒疗法中获得了预期的益处,并且诸如肾病等与HIV相关的疾病仍在高危人群中发生。目前,尚无针对HIV阳性患者进行HIV相关肾病筛查的建议。我们建议对HIV阳性的非裔美国人以及有肾脏疾病家族史的患者每半年进行一次蛋白尿筛查,并提供一种评估算法。